All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
ROIVANT SCIENCES LTD. Last Reported: 5/31/2024 Stock Symbol: ROIV

Business Address

CLARENDON HOUSE, 2 CHURCH STREET

HAMILTON HM11 , BM HM11

Mailing Address

CLARENDON HOUSE
2 CHURCH STREET
HAMILTON , BM HM11
Phone Number: 441-295-5950 / State Incorporated: / Fiscal Year End 3 /31

Balance Sheet

Date 12/31/2023 9/30/2023 6/30/2023 12/31/2022 9/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 3/31/2020
Cash and Cash Equivalents $6,670,810,000.00 $1,400,000,000.00 $1,434,093,000.00 $1,527,437,000.00 $1,599,021,000.00 $2,100,000,000.00 $2,214,283,000.00 $2,500,000,000.00 $2,000,000,000.00 $2,055,044,000.00 $2,183,207,000.00
Accounts Receivable Net Current -- -- -- -- -- -- $8,921,000.00 $9,814,000.00 $3,416,000.00 $11,222,000.00 $3,669,000.00
Inventory $5,240,000.00 $4,905,000.00 $4,225,000.00 -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets -- -- -- -- -- -- -- -- -- -- --
Total Current Assets $6,806,733,000.00 $1,551,627,000.00 $1,561,158,000.00 $1,646,232,000.00 $1,714,861,000.00 $2,146,523,000.00 $2,287,533,000.00 $2,555,754,000.00 $2,057,609,000.00 $2,186,995,000.00 $2,219,245,000.00
Property Plant and Equipement $21,857,000.00 $24,477,000.00 $36,270,000.00 $37,295,000.00 $39,171,000.00 $25,905,000.00 $21,606,000.00 $16,904,000.00 $15,550,000.00 $14,749,000.00 $8,962,000.00
Intangible Assets Net $150,415,000.00 $140,621,000.00 $145,037,000.00 $146,105,000.00 $140,298,000.00 -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- --
Other Assets $46,849,000.00 $49,796,000.00 $46,307,000.00 $46,223,000.00 $11,874,000.00 $16,092,000.00 $20,875,000.00 $21,337,000.00 $26,520,000.00 $27,197,000.00 $6,659,000.00
Total Assets $7,312,679,000.00 $2,065,543,000.00 $2,136,646,000.00 $2,202,960,000.00 $2,215,534,000.00 $2,585,129,000.00 $2,799,375,000.00 $3,102,906,000.00 $2,454,697,000.00 $2,589,692,000.00 $2,477,051,000.00
Accounts Payable $35,226,000.00 $44,123,000.00 $50,035,000.00 $47,999,000.00 $41,358,000.00 $34,583,000.00 $24,358,000.00 $77,158,000.00 $15,014,000.00 $20,550,000.00 $10,306,000.00
Accrued Liabilities $122,148,000.00 $152,923,000.00 $119,329,000.00 $132,359,000.00 $128,815,000.00 $127,531,000.00 $112,679,000.00 $104,111,000.00 $73,788,000.00 $76,936,000.00 $68,621,000.00
Total Current Liabilities $728,097,000.00 $739,910,000.00 $802,507,000.00 $775,822,000.00 $701,385,000.00 $523,695,000.00 $529,622,000.00 $652,007,000.00 $474,865,000.00 $527,687,000.00 $368,356,000.00
Long Term Debt $403,337,000.00 $389,445,000.00 $385,069,000.00 $375,124,000.00 $376,058,000.00 $210,025,000.00 $204,042,000.00 $199,869,000.00 $186,350,000.00 $170,280,000.00 $108,592,000.00
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $-27,784,000.00 $-3,072,000.00 $-6,610,000.00 $-729,000.00 $9,089,000.00 $-946,000.00 $-1,070,000.00 $1,281,000.00 $-1,207,000.00 $1,445,000.00 $-2,349,000.00
Accumulated Deficit $727,300,000.00 $-4,400,000,000.00 $-4,064,570,000.00 $-3,739,137,000.00 $-3,387,123,000.00 $-2,763,724,000.00 $-2,500,000,000.00 $-2,200,000,000.00 $-2,000,000,000.00 $-1,918,462,000.00 $-1,109,228,000.00
Total Stockholders' Equity $6,089,763,000.00 $948,534,000.00 $910,730,000.00 $955,520,000.00 $1,160,601,000.00 $1,656,944,000.00 $1,865,720,000.00 $2,038,015,000.00 $1,723,122,000.00 $1,797,788,000.00 $2,032,162,000.00
Controlling Interest in Subsidiaries $494,819,000.00 $377,099,000.00 $423,409,000.00 $471,618,000.00 $353,548,000.00 $381,999,000.00 $381,542,000.00 $390,393,000.00 $234,219,000.00 $241,726,000.00 $54,042,000.00
Total Liabilities and Equity $7,312,679,000.00 $2,065,543,000.00 $2,136,646,000.00 $2,202,960,000.00 $2,215,534,000.00 $2,585,129,000.00 $2,799,375,000.00 $3,102,906,000.00 $2,454,697,000.00 $2,589,692,000.00 $2,477,051,000.00

Statement of Operations

Date 12/31/2023 9/30/2023 6/30/2023 12/31/2022 9/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 3/31/2020
Total Revenues -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- --
Research and Development $380,834,000.00 $257,117,000.00 $125,133,000.00 $125,533,000.00 $131,995,000.00 $483,035,000.00 $486,335,000.00 $254,259,000.00 $78,626,000.00 $832,758,000.00 $263,217,000.00
Selling, General, and Administrative $197,282,000.00 $320,545,000.00 $156,190,000.00 $168,261,000.00 $157,663,000.00 -- -- -- -- -- --
Total Operating Expenses $936,259,000.00 $611,592,000.00 $298,037,000.00 $975,056,000.00 $293,299,000.00 $1,406,928,000.00 $270,364,000.00 $698,416,000.00 $162,122,000.00 $1,094,693,000.00 $600,114,000.00
Loss from Operations $4,508,016,000.00 $-552,867,000.00 $-276,413,000.00 $-378,077,000.00 $-280,766,000.00 $-1,351,642,000.00 $-1,084,839,000.00 $-684,429,000.00 $-154,387,000.00 $-1,070,898,000.00 $-532,425,000.00
Loss Before Income Taxes $4,444,883,000.00 $-653,454,000.00 $-326,093,000.00 $-1,045,618,000.00 $-313,756,000.00 $-923,747,000.00 $-306,047,000.00 $-225,239,000.00 $-100,985,000.00 -- --
Earnings Per Share Basic $5.79 $-0.78 $-0.38 $-0.49 $-0.42 $-1.26 -- -- -- -- --
Weighted Average Shares Basic 776,759,728 764,780,630 759,273,550 703,054,773 697,894,414 669,753,458 -- -- -- 215,312,273 219,036,630
Earnings Per Share Diluted $5.46 $-0.78 $-0.38 $-1.39 $-0.42 $-1.26 -- -- -- -- --
Weighted Average Shares Diluted 844,461,685 764,780,630 759,273,550 713,319,399 699,888,061 669,753,458 -- -- -- 215,312,273 219,036,630
Common Stock Shares Authorized 7,000,000,000 7,000,000,000 7,000,000,000 7,000,000,000 7,000,000,000 7,000,000,000 7,000,000,000 7,000,000,000 100,000,000,000 100,000,000,000 100,000,000,000
Common Stock Shares Outstanding 804,890,910 800,792,365 767,137,861 726,804,831 704,386,981 694,975,965 692,012,183 684,789,169 222,669,799 222,669,799 214,879,058
Common Stock Value -- -- -- -- -- -- -- -- -- -- --
Common Stock Par Or Stated Value Per Share -- -- -- -- -- -- -- -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share -- -- -- -- -- -- -- -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com